スーパー崩壊剤の世界市場：クロスカルメロースナトリウム、クロスポビドン、デンプングリコール酸ナトリウム、イオン交換樹脂...市場調査レポートについてご紹介

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 26)

4 Premium Insights (Page No. – 30)
4.1 Market Overview
4.2 Asia-Pacific: Market, By Product (2015)
4.3 Geographic Snapshot of the Market
4.4 Regional Mix of the Market
4.5 Market: Developed vs Developing Countries

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Product
5.2.2 By Application
5.2.3 By Therapeutic Area
5.3 Key Market Dynamics
5.3.1 Drivers
5.3.1.1 Growing Generics Market
5.3.1.2 Growing Population of Geriatric and Pediatric Patients
5.3.1.3 Emergence of New Superdisintegrants for the Pharmaceutical Industry
5.3.2 Restraints
5.3.2.1 Declining R&D Investments in Superdisintegrants Development
5.3.3 Opportunities
5.3.3.1 Market Expansion in Emerging Countries
5.3.3.2 Rising Healthcare Expenditure
5.3.4 Challenges
5.3.4.1 Quality Concerns Demanding Greater Transparency in Supply Chain
5.3.4.2 Formulation of Palatable Odts

6 Industry Insights (Page No. – 43)
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Nutraceuticals Market Driving the Demand for Superdisintegrants
6.2.2 Rising Focus of the Pharmaceutical Industry on Orally Disintegrating Tablets
6.3 Regulatory Analysis
6.3.1 North America:
6.3.1.1 U.S.
6.3.1.2 Canada
6.3.2 Europe
6.3.3 APAC
6.3.3.1 Japan
6.3.3.2 China
6.3.3.3 India
6.4 Porter’s Five Forces Analysis
6.4.1 Threat of New Entrants
6.4.2 Threat of Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry

7 Superdisintegrants Market, By Product (Page No. – 51)
7.1 Introduction
7.2 Natural Superdisintegrants
7.3 Synthetic Superdisintegrants
7.3.1 Modified Starch (Sodium Starch Glycolate)
7.3.2 Modified Cellulose
7.3.2.1 Croscarmellose-Sodium
7.3.2.2 Low-Substituted Hydroxypropyl Cellulose (L-HPC)
7.3.3 Crospovidone
7.3.4 ION Exchange Resins
7.3.5 Calcium Silicates
7.4 Others

8 Superdisintegrants Market, By Application (Page No. – 67)
8.1 Introduction
8.2 Tablets
8.3 Capsules

9 Superdisintegrants Market, By Therapeutic Area (Page No. – 73)
9.1 Introduction
9.2 Gastrointestinal Diseases
9.3 Neurological Diseases
9.4 Oncology
9.5 Infectious Diseases
9.6 Cardiovascular Diseases
9.7 Hematological Diseases
9.8 Inflammatory Diseases

10 Geographic Analysis (Page No. – 83)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Switzerland
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 U.K.
10.3.6 Spain
10.3.7 Rest of Europe (RoE)
10.4 Asia-Pacific (APAC)
10.4.1 Japan
10.4.2 India
10.4.3 China
10.4.4 Rest of Asia-Pacific (RoAPAC)
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.2 Middle East and Africa

11 Competitive Landscape (Page No. – 137)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Expansions
11.3.2 New Product Launches
11.3.3 Acquisitions
11.3.4 Collaborations
11.3.5 Others

12 Company Profiles (Page No. – 145)
(Overview, Financial*, Products & Services, Strategy, and Developments)
12.1 Introduction
12.2 Ashland Inc.
12.3 BASF SE
12.4 FMC Corporation
12.5 DFE Pharma
12.6 JRS Pharma
12.7 Roquette
12.8 The DOW Chemical Company
12.9 Asahi Kasei Corporation
12.10 Nippon Soda Co., Ltd.
12.11 Huber Corporation

*Details Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 163)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports